Chronic News and Research

RSS

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.

9 Jan 2014

Hebrew University research could lead to efficient and fast-acting antidepressant drugs

The World health Organization calls depression "the leading cause of disability worldwide," causing more years of disability than cancer, HIV/AIDS, and cardiovascular and respiratory diseases combined.

8 Jan 2014

Nociceptin in brain naturally moderates effects of stress

Collaborating scientists at The Scripps Research Institute (TSRI), the National Institutes of Health (NIH) and the University of Camerino in Italy have published new findings on a system in the brain that naturally moderates the effects of stress.

8 Jan 2014

AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

Advanced Inhalation Therapies, an Israeli drug development company, announced today that it has begun enrollment in Israel for a multicenter, open label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis.

8 Jan 2014

IDMC recommends early stopping of Phase 3 study of ibrutinib in treatment of CLL/SLL

Janssen-Cilag International NV today announced the early stopping of PCYC-1112-CA, the Phase 3 study of ibrutinib in the treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, based on the recommendation of an Independent Data Monitoring Committee, which concluded that the study showed a significant difference in progression-free survival as compared to the control, the primary endpoint of the study.

8 Jan 2014

WHO delivers over 125 tons of medical equipment, medicines to health providers in Aleppo

Over the past 2 weeks WHO delivered 2 shipments with more than 125 tons of medical equipment and medicines to health providers in Aleppo, Syrian Arab Republic - in both government-controlled and in opposition-controlled areas. All shipments contained surgical materials, medicines to treat chronic and infectious diseases, infant incubators, ventilators and intensive care unit beds.

8 Jan 2014

IQWiG study finds no added benefit of teriflunomide

Teriflunomide (trade name: Aubagio) has been approved in Germany since August 2013 for adults with relapsing remitting multiple sclerosis. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products, the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

8 Jan 2014

RESOLUTE selected to provide Patient and Guest Wi-Fi service for VA San Diego Healthcare System

RESOLUTE Partners, a leading provider of Guest Internet access and fixed wireless communications solutions for government and commercial applications has been selected to provide Patient and Guest Wi-Fi service throughout the VA San Diego Healthcare System, La Jolla Village Drive campus.

8 Jan 2014

Study links racism-related factors and biological aging among African American men

A new study reveals that racism may impact aging at the cellular level. Researchers found signs of accelerated aging in African American men, ages reporting high levels of racial discrimination and who had internalized anti-Black attitudes.

8 Jan 2014

Research opens door to new direction of PAH treatment

The development of new, more effective vasodilators to treat pulmonary arterial hypertension has been hampered because of their systemic toxicity and adverse side effects. An international team of investigators seeking to surmount these problems and increase drug efficacy have determined that a vascular homing peptide can selectively target hypertensive pulmonary arteries to boost the pulmonary but not systemic effects of vasodilators. Importantly for potential clinical use, this peptide retains its activity when given sublingually. The results using a rat model of PAH are published in the American Journal of Pathology.

8 Jan 2014

A&D Medical releases secure, flexible platform to help people manage their health

For everyone from patients to quantified selfers, A&D Medical today announced the release of its next generation Wellness Connected®, a secure, flexible platform to help people increase physical activity and manage their health.

7 Jan 2014

Sverica’s additional investment supports RestorixHealth's acquisition of Candescent Healing

Sverica International Management LLC, a private equity investment firm, announced today that it made an additional equity investment in RestorixHealth, a comprehensive wound care management company.

7 Jan 2014

Low gut microbial diversity in infants' intestines can increase risk for asthma

Low gut microbial diversity in the intestines of infants can increase the risk for asthma development. These are the findings of the age 7 follow-up in a multi-year study led by researchers at Linköping University in Sweden.

7 Jan 2014

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Alitair Pharmaceuticals, Inc., today announced that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for its drug candidate, Erdosteine, for the treatment of bronchiectasis. Erdosteine is a mucolytic with antibacterial, anti-inflammatory, and antioxidant properties.

7 Jan 2014

Ihealth unveils new wearable personal health devices at CES 2014

Today, iHealth Lab Inc., announced the extension of its suite of personal mobile health devices to include a line of wearable products designed to provide monitoring over an extended period of time.

7 Jan 2014

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

Shield Therapeutics, an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from the pivotal Phase 3 programme of ST10 for the treatment of iron deficiency anaemia in inflammatory bowel disease.

7 Jan 2014

DASH diet wins Best Diets Overall, while Weight Watchers continues to hold No. 1 spot for Best Weight-Loss Diets

As many Americans resolve to lose weight and lead healthier lifestyles in the new year, U.S. News & World Report today released its Best Diets 2014, featuring rankings and information on 32 diet plans.

7 Jan 2014

Study shows binge-eating disorder is associated with substantial lifelong impairments

Binge-eating disorder, designated in 2013 by the American Psychiatric Association as a diagnosis in its Diagnostic and Statistical Manual of Mental Disorders-V, is associated with substantial lifelong impairments comparable to those of bulimia nervosa, according to a recent World Health Organization study based on community epidemiological surveys conducted in 12 nations worldwide.

7 Jan 2014

Research: Daily meditation may improve symptoms of anxiety and depression

Some 30 minutes of meditation daily may improve symptoms of anxiety and depression, a new Johns Hopkins analysis of previously published research suggests.

7 Jan 2014

Study examine effect of high out-of-pocket drug costs for targeted cancer therapies on patients

The cost of insurance co-payments for cutting-edge pharmaceuticals can vary widely from patient to patient. When the patient's share of prescription costs becomes too high, many patients skip doses or stop taking medication entirely, according to research conducted at the University of North Carolina.

6 Jan 2014

Chronic News and Research

Proteon's PRT-201 gets orphan drug designation for prevention of arteriovenous access dysfunction

Hebrew University research could lead to efficient and fast-acting antidepressant drugs

Nociceptin in brain naturally moderates effects of stress

AIT initiates Phase II clinical trial of NOxCureCF for patients with cystic fibrosis

IDMC recommends early stopping of Phase 3 study of ibrutinib in treatment of CLL/SLL

WHO delivers over 125 tons of medical equipment, medicines to health providers in Aleppo

IQWiG study finds no added benefit of teriflunomide

RESOLUTE selected to provide Patient and Guest Wi-Fi service for VA San Diego Healthcare System

Study links racism-related factors and biological aging among African American men

Research opens door to new direction of PAH treatment

A&D Medical releases secure, flexible platform to help people manage their health

Sverica’s additional investment supports RestorixHealth's acquisition of Candescent Healing

Low gut microbial diversity in infants' intestines can increase risk for asthma

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Ihealth unveils new wearable personal health devices at CES 2014

Shield Therapeutics reports positive top-line data from pivotal Phase 3 programme of ST10

DASH diet wins Best Diets Overall, while Weight Watchers continues to hold No. 1 spot for Best Weight-Loss Diets

Study shows binge-eating disorder is associated with substantial lifelong impairments

Research: Daily meditation may improve symptoms of anxiety and depression

Study examine effect of high out-of-pocket drug costs for targeted cancer therapies on patients

Industry Focus eBook - Cell biology (5th edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News